Patented Technologies for Added Value
Altus owns a range of patented, value added technologies to create Value Added Medicines with unique features for unique labeling. Our technologies enable fast market uptake and sustained market share.
Altus Enabling Technologies: another Altus Advantage.
FlexiTab™ Tablets: Simple to manufacture breakable, modified release tablets generating up to four dose-proportional tablet segments from each unit dose.
Ideal for geriatric and pediatric formulations, Flexitab tablets provide cost-effective strategies for precise patient titration, avoidance of side-effects and improved efficacy.
Marketed in over 25 countries including US, EU and Japan, Flexitab technology has been used to commercialize a range of breakable Value Added Medicines including single API and fixed-dose combinations (FDC).
SmartCelle Micelles: SmartCelle micelles are 20-50 nanometer dynamic nanoparticles that enable insoluble drug delivery via multiple administration routes including oral, intravenous and most importantly ocular delivery. SmartCelle micelles can increase solubility many thousand-fold enabling increased bioavailability and bio-distribution.
FlexiTab™ ODT: Taste-masked instant release and breakable extended release orally-disintegrating tablets with excellent mouthfeel for those with swallowing challenges or when fast onset is a must.